TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,489,000 | +81.1% | 198,699 | 0.0% | 1.27% | +85.1% |
| Q2 2021 | $1,927,000 | -9.7% | 198,699 | 0.0% | 0.68% | -25.0% |
| Q1 2021 | $2,134,000 | -17.0% | 198,699 | +13.7% | 0.91% | -21.5% |
| Q4 2020 | $2,570,000 | +2.6% | 174,699 | -0.9% | 1.16% | -20.8% |
| Q3 2020 | $2,504,000 | +17.1% | 176,215 | -33.3% | 1.47% | +25.9% |
| Q2 2020 | $2,138,000 | +288.0% | 264,225 | +93.6% | 1.17% | +235.3% |
| Q1 2020 | $551,000 | – | 136,500 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
| Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
| COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
| Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
| Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
| ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
| NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
| Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
| Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |